Use of basal insulin and the associated clinical outcomes among elderly nursing home residents with type 2 diabetes mellitus: a retrospective chart review study

Código QR

Use of basal insulin and the associated clinical outcomes among elderly nursing home residents with type 2 diabetes mellitus: a retrospective chart review study

Keith L Davis,1 Wenhui Wei,2 Juliana L Meyers,1 Brett S Kilpatrick,3 Naushira Pandya4 1RTI Health Solutions, Research Triangle Park, NC, USA; 2Sanofi US, Inc, Bridgewater, NJ, USA; 3AnalytiCare, LLC, Glenview, IL, USA; 4Nova Southeastern University College of Osteopathic Medicine, Fort Lauderdale,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Davis KL, Wei W, Meyers JL, Kilpatrick BS, Pandya N
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	long-term care nursing homes type 2 diabetes mellitus insulin detemir insulin glargine NPH insulin Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/cfab3310b7b04c729af73af7568abfab
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
por: Lau IT, et al.
Publicado: (2017)

Basal insulin therapy in patients with type 2 diabetes mellitus and poor control of glycemia by oral hypoglycemic agents: results of direct comparative study of insulin analogs Lantus and Levemir
por: Alsu Gafurovna Zalevskaya, et al.
Publicado: (2010)

Enzyme-Linked Immunosorbent Assay Method Application in the Study of Comparative Pharmacokinetics of Insulin Glargin Preparations
por: L. N. Shitov, et al.
Publicado: (2019)

Análogos de insulina: en búsqueda del reemplazo fisiológico
por: Eyzaguirre C,Francisca, et al.
Publicado: (2006)

Combined insulin detemir and liraglutide therapy in type 2 diabetic patients: a base for an alliance
por: Lyudmila Alexandrovna Ruyatkina, et al.
Publicado: (2017)

rDNA insulin glargine U300 – a critical appraisal
por: Wang F, et al.
Publicado: (2016)

On the safety of insulin Glargine
por: Ivan Ivanovich Dedov, et al.
Publicado: (2009)

Priority areas in management of diabetes mellitus type 1 & 2 (following 47th EASD Annual Meeting)
por: Ivona Renata Yarek-Martynova, et al.
Publicado: (2011)

Lantus, the first peakless basal insulin analogue: 10 years of clinical experience in children and adolescents
por: Tamara Leonidovna Kuraeva
Publicado: (2014)

A Difference Between Bedtime and Pre-Breakfast Plasma Glucose Levels Indicates the Need for Prandial Insulin in Basal Insulin-Treated Type 2 Diabetic Patients with Normal Fasting Glucose
por: Kress S, et al.
Publicado: (2021)

Insulin degludec/insulin aspart is the first co-formulation of basal and prandial insulin analogues
por: Ivan Ivanovich Dedov, et al.
Publicado: (2014)

Insulin glargine does not increase the risk of malignancy.Synopsis of the article ?Combined randomised controlled trial experience of malignancies in studies using insulin glargine?byHome P.D. & Lagarenne P. (Diabetologia 2009, vol. 52 (12): 2499-2506)
por: Marina Vladimirovna Shestakova, et al.
Publicado: (2010)

Falls in nursing home residents receiving pharmacotherapy for anemia
por: Reardon G, et al.
Publicado: (2012)

Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics
por: Le Floch J
Publicado: (2010)

Effect of Adding Insulin Glargine on Glycemic Control in Critically Ill Patients Admitted to Intensive Care Units: A Prospective Randomized Controlled Study
por: Nader ND, et al.
Publicado: (2020)

Insulin glargine: pharmacokinetic and pharmacodynamic basis of clinical effect
por: Vadim Valer'evich Klimontov, et al.
Publicado: (2014)

When basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus
por: Elena V. Buryukova, et al.
Publicado: (2017)

The first and only combination of basal and prandial insulin analogs degludec and aspart: the position of Russian endocrinologists
por: M. V. Shestakova, et al.
Publicado: (2021)

Insulin signaling proteins in pancreatic islets of insulin-resistant rats induced by glucocorticoid
por: De Paula,Flávia MM, et al.
Publicado: (2011)

Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience
por: Chan WB, et al.
Publicado: (2017)

Association of Insulin Glargine Treatment with Bone Mineral Density in Patients with Type 2 Diabetes Mellitus
por: Liu D, et al.
Publicado: (2021)

Modern basal insulins: an ongoing story or the start of a new era?
por: Ivan Ivanovich Dedov
Publicado: (2015)

Real-World Effectiveness of Insulin Glargine 300 Initiation in Switzerland
por: Thomann R, et al.
Publicado: (2020)

Pengaruh Latihan Fisik terhadap Perbaikan Resistensi Insulin
por: Devitya Angielevi Sukarno
Publicado: (2021)

Overcoming marked insulin resistance in a patient with type 2 diabetes mellitus by means of insulin pumptherapy
por: Ekaterina Viktorovna Artemova, et al.
Publicado: (2012)

Insulin degludec: a new basal insulin analogue with an ultra-long duration of action. Safety and efficacy in Russian patients with diabetes
por: Marina Vladimirovna Shestakova, et al.
Publicado: (2015)

Características clínicas y metabólicas de los estados de intolerancia a la glucosa y glicemia de ayuno alteradas
por: Arteaga,Antonio, et al.
Publicado: (2009)

Detemir potential applications in the treatment of diabetes during pregnancy: proven benefits and perspectives
por: Lyudmila A. Ruyatkina, et al.
Publicado: (2016)

Achieving Effective and Efficient Basal Insulin Optimal Management by Using Mobile Health Application (APP) for Type 2 Diabetes Patients in China
por: Cai X, et al.
Publicado: (2020)

Effective and safe control of glycemia with insulin Apidra - the recipe for success of type 2 diabetes prophylaxis
por: Elena Valer'evna Biryukova
Publicado: (2011)

La insulinoterapia intensificada más antineuríticos es superior a antineurítico puro en neuropatía diabética dolorosa
por: Bastías A,M Juliana, et al.
Publicado: (2006)

RELUCTANCE OF PATIENTS WITH DIABETES MELLITUS TO INSULIN THERAPY; PSYCHOLOGICAL INSULIN RESISTANCE
por: Umair Ali, et al.
Publicado: (2021)

An Application of Queueing Theory to the Relationship Between Insulin Level and Number of Insulin Receptors
por: Cagin Kandemir-Cavas, et al.
Publicado: (2007)

Risk of oncological diseases in patients with diabetes mellitus
por: Gagik Radikovich Galstyan
Publicado: (2009)

Nursing homes long term care management.
Publicado: (1991)

The long-term effects of the health coaching self-management program for nursing-home residents
por: Park YH, et al.
Publicado: (2017)

Lypohypertrophy in patients receiving insulin therapy: state of the art
por: Natalya Ivanovna Volkova, et al.
Publicado: (2011)

Effects of Coffee Consumption on Insulin Resistance and Sensitivity: A Meta-Analysis
por: Su-Min Moon, et al.
Publicado: (2021)

Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
por: Schwartz S
Publicado: (2010)

Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications
por: Wondmkun YT
Publicado: (2020)